Related Experiment Videos
Childhood vitiligo successfully treated with bath PUVA
D W Mai1, C Omohundro, J W Dijkstra
1Department of Dermatology, Cleveland Clinic Foundation, Ohio 44195-5032, USA.
Insights
Pediatric vitiligo can be treated with bath psoralen plus ultraviolet A (PUVA) therapy. This method offers a safer alternative for children, minimizing systemic absorption and ultraviolet A exposure.
Area of Science:
- Dermatology
- Pediatric Dermatology
- Phototherapy
Background:
- Vitiligo is a significant concern in pediatric populations.
- Systemic PUVA therapy is effective but not recommended for children due to safety concerns.
- Alternative, safer treatment options are needed for pediatric vitiligo.
Observation:
- A 9-year-old Caucasian girl presented with progressive vitiligo.
- The patient underwent successful treatment with bath PUVA therapy.
Findings:
- Bath PUVA therapy demonstrated effectiveness in treating pediatric vitiligo.
- This method requires less ultraviolet A (UVA) radiation exposure compared to systemic PUVA.
- Systemic absorption of psoralen is minimal with bath PUVA.
Implications:
- Bath PUVA therapy presents a potentially safer treatment option for children with vitiligo.
- This approach may overcome the limitations of systemic PUVA in pediatric patients.
- Further research into bath PUVA for pediatric dermatological conditions is warranted.
Abstract:
A significant proportion of vitiligo patients are children. Systemic PUVA therapy, the most consistently effective and practical therapy for this disease, has not been recommended in pediatric patients because of concerns regarding potential long-term side effects. We report a 9-year-old Caucasian girl with progressive vitiligo who was successfully treated with bath PUVA. This form of PUVA therapy may provide a wider margin of safety, in that less exposure to ultraviolet A (UVA) radiation is required and systemic absorption of psoralen is minimal.